Some GEMMs have combined overexpression of the oncogenes Egfr or Ggfb3 with tumor suppressor mutation by driving oncogene expression in nervous system cells using CNP or P0 promoters, respectively [57, 80, 81, 84, 85]. The gene discussed is EGFR; the disease is neoplasm.